Photochemical properties of kynurenine pathway metabolites and indoleamines

被引:0
|
作者
Goda, K [1 ]
Amako, K [1 ]
Kishimoto, R [1 ]
Ogiri, Y [1 ]
机构
[1] Kobe Gakuin Univ, Fac Nutr, Nish Ku, Kobe, Hyogo 6512180, Japan
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Photochemical damages to the biological system may occur through photodynamic action in the presence of photosensitive molecules. Photodynamic action contains, the following processes; 1) photosensitisation and/or 2) electron transfer, in which singlet oxygen and superoxide radical production for each in the presence of oxygen molecules. We have studied those processes after the absorption of light by kynurenine pathway metabolites and indoleamine derivatives. We found that kynurenine and 3-hydroxykynurenine generate superoxide radical after electron transfer from their excited state molecules to oxygen molecules, and superoxide makes reduction reaction. On the other hand, it was found that kynurenic acid, melatonin, 5-methoxytryptamine and 5-methoxytryptophol work as photosensitisers with the detection of singlet oxygen production by using the N, N-dimethyl-4-nitrosoaniline bleaching method, while xanthurenic acid, serotonin and N-acetylserotonin generate no detectable amount of singlet oxygen. We have determined the photochemical quantum yields of singlet oxygen production for those photosensitisers, in which quantum yields are not so high except kynurenic acid (f(3)= 0.101). In view of the multiple roles played by their metabolites in various systems, these results are relevant to taking into consideration of their photo-effect in the presence of light.
引用
收藏
页码:687 / 693
页数:7
相关论文
共 50 条
  • [1] Kynurenine pathway metabolites and suicidality
    Bryleva, Elena Y.
    Brundin, Lena
    NEUROPHARMACOLOGY, 2017, 112 : 324 - 330
  • [2] Kynurenine pathway metabolites in migraine
    Ferdinando Nicoletti
    The Journal of Headache and Pain, 2015, 16
  • [3] Kynurenine pathway metabolites in migraine
    Nicoletti, Ferdinando
    JOURNAL OF HEADACHE AND PAIN, 2015, 16 : 1
  • [4] Kynurenine pathway metabolites in cluster headache
    Curto, Martina
    Lionetto, Luana
    Capi, Matilde
    Negro, Andrea
    D'Alonzo, Lidia
    Nicoletti, Ferdinando
    Martelletti, Paolo
    JOURNAL OF HEADACHE AND PAIN, 2015, 16 : 1
  • [5] Kynurenine Pathway Metabolites in Alzheimer's Disease
    Giil, Lasse Melvaer
    Midttun, Oivind
    Refsum, Helga
    Ulvik, Arve
    Advani, Rajiv
    Smith, A. David
    Ueland, Per Magne
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 495 - 504
  • [6] Kynurenine Pathway Metabolites as Modulators of Glutamatergic Neurotransmission
    Schwarcz, R.
    Sathyasaikumar, K. V.
    Tararina, M.
    Wu, H. -Q.
    Bortz, D. M.
    Bruno, J. P.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 55 - 55
  • [7] Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure
    Pawlak, D
    Tankiewicz, A
    Matys, T
    Buczko, W
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 54 (02): : 175 - 189
  • [8] Measurement of kynurenine pathway metabolites by tandem mass spectrometry
    Abusoglu, Sedat
    Onmaz, Duygu Eryavuz
    Abusoglu, Gulsum
    Yerlikaya, Fatma Humeyra
    Unlu, Ali
    JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB, 2023, 28 : 114 - 121
  • [9] Early Life Stress and the Fate of Kynurenine Pathway Metabolites
    Coplan, Jeremy D.
    George, Roza
    Syed, Shariful A.
    Rozenboym, Annalam V.
    Tang, Jean E.
    Fulton, Sasha L.
    Perera, Tarique D.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2021, 15
  • [10] Kynurenine Pathway Metabolites in Humans: Disease and Healthy States
    Chen, Yiquan
    Guillemin, Gilles J.
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2009, 2 : 1 - 19